Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)
- PMID: 20519663
- PMCID: PMC2945153
- DOI: 10.2337/dc09-1150
Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)
Abstract
Objective: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have different pathophysiological abnormalities, and their combination may influence the effectiveness of the primary prevention tools. The hypothesis was tested in this analysis, which was done in a pooled sample of two Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
Research design and methods: Researchers analyzed and followed up on the details of 845 of the 869 IGT subjects in the two studies for 3 years. Incidence of diabetes and reversal to normoglycemia (normal glucose tolerance [NGT]) were assessed in group 1 with baseline isolated IGT (iIGT) (n = 667) and in group 2 with IGT + IFG (n = 178). The proportion developing diabetes in the groups were analyzed in the control arm with standard advice (IDPP-1) (n = 125), lifestyle modification (LSM) (297 from both), metformin (n = 125, IDPP-1), and LSM + metformin (n = 121, IDPP-1) and LSM + pioglitazone (n = 298, IDPP-2). Cox regression analysis was used to assess the influence of IGT + IFG versus iIGT on the effectiveness of the interventions.
Results: Group 2 had a higher proportion developing diabetes in 3 years (56.2 vs. 33.6% in group 1, P = 0.000) and a lower rate of reversal to NGT (18 vs. 32.1%, P = 0.000). Cox regression analysis showed that effectiveness of intervention was not different in the presence of fasting and postglucose glycemia after adjusting for confounding variables.
Conclusions: The effectiveness of primary prevention strategies appears to be similar in subjects with iIGT or with combined IGT + IFG. However, the possibility remains that a larger study might show that the effectiveness is lower in those with the combined abnormality.
Figures

Similar articles
-
Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).Diabetes Care. 2009 Oct;32(10):1796-801. doi: 10.2337/dc09-0676. Epub 2009 Jul 8. Diabetes Care. 2009. PMID: 19587369 Free PMC article. Clinical Trial.
-
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).Diabetologia. 2006 Feb;49(2):289-97. doi: 10.1007/s00125-005-0097-z. Epub 2006 Jan 4. Diabetologia. 2006. PMID: 16391903 Clinical Trial.
-
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.Diabetes Obes Metab. 2014 Apr;16(4):326-33. doi: 10.1111/dom.12220. Epub 2013 Oct 29. Diabetes Obes Metab. 2014. PMID: 24118860 Free PMC article. Clinical Trial.
-
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x. Diabet Med. 2002. PMID: 12207806 Review.
-
Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.Diab Vasc Dis Res. 2005 Feb;2(1):9-15. doi: 10.3132/dvdr.2005.007. Diab Vasc Dis Res. 2005. PMID: 16305067 Review.
Cited by
-
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD013516. doi: 10.1002/14651858.CD013516.pub2. Cochrane Database Syst Rev. 2020. PMID: 33210751 Free PMC article.
-
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review.Commun Med (Lond). 2023 Oct 5;3(1):133. doi: 10.1038/s43856-023-00363-0. Commun Med (Lond). 2023. PMID: 37794109 Free PMC article.
-
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article.
-
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.Ann Intern Med. 2015 Sep 15;163(6):437-51. doi: 10.7326/M15-0452. Ann Intern Med. 2015. PMID: 26167912 Free PMC article.
-
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Drugs. 2015. PMID: 26059289 Free PMC article. Review.
References
-
- DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281– 303 - PubMed
-
- Snehalatha C, Ramachandran A, Sivasankari S, Satyavani K, Vijay V: Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians. Diabete Metab Res Rev 2003; 19: 329– 332 - PubMed
-
- de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 2001; 285: 2109– 2113 - PubMed
-
- Eschwège E, Charles MA, Simon D, Thibult N, Balkau B: Paris Prospective Study Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001; 24: 1941– 1944 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical